Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRVL | CBOE Canada | CAD | Real-time | |
MRVL | TSXV | CAD | Delayed |
For the six months ended 12 January 2022, Marvel Biosciences Corp revenues was not reported. Net loss totaled to C$1.6M. Results are not comparable due to year end change.
Period Ending: | Jan 12, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -1.07 | -0.51 | -3.11 | -0.01 |
Net Income | -1.07 | -0.51 | -2.99 | -0.01 |
Period Ending: | Jan 12, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 |
---|---|---|---|---|
Total Assets | 0.92 | 2.15 | 2.47 | 0.39 |
Total Liabilities | 0.15 | 0.3 | 0.11 | 0 |
Total Equity | 0.78 | 1.85 | 2.36 | 0.39 |
Period Ending: | Jan 12, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -1.53 | -0.27 | -1.37 | -0.05 |
Cash From Investing Activities | 0.38 | 0.4 | ||
Cash From Financing Activities | 0 | 0 | 3.16 | 0.03 |
Net Change in Cash | -1.53 | -0.27 | 2.17 | 0.39 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review